During this year, we aimed to express four chosen enzymes into an E. coli strain, since it is the most practical and known bacteria, and test their expression and functionality in this chassis: this was a necessary step since three out of our four chosen enzymes are not native to E. coli species and the effects of this change of host are not yet known.
To achieve this, we designed and synthesized novel expression cassettes codifying specific dehalogenases or laccases that will be expressed internally or externally, through the insertion of the display system Lpp-OmpT, on the E. coli strain. After, expression and functionality tests were performed to verify the correct expression of the translated protein, ideally
comparing enzyme localization both inside and outside the bacteria membrane, and the enzymatic activity of each protein through the use of a known substrate.
The chosen backbone pJUMP29-1A was fundamental for our clonings since it presents a terminator right after the Biobrick suffix. Since the synthesis facility wasn’t able to synthesize an expression cassette that included a terminator itself, the presence of this Lambda terminator downstream of the Suffix element came in handy for designing and building our system.
During the design of our basic and composite parts, we decided to include in our sequences the NdeI restriction site, formed by a six-base sequence “CATATG”. This particular site was chosen for different possible procedures, but it is always necessary since the “ATG” triplet in the recognition site overlaps the starting codon ATG of our coding sequences, and is needed due to its closer position to the start of the gene.
At this point we faced a problem: pJUMP29-1A presents an NdeI site inside its sequence.
So our solution was to mutate the backbone through mutagenic PCR to remove the unwanted site.
The restriction site mapped on the backbone but was outside of Ori and the kanamycin resistance gene, so it was easier to modify without damaging the plasmid structure.
The sequence that encodes the site was:
5’–CCTTACGCATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAG–3’
We designed two primers forward and reverse overlapping the restriction site, both of them with a single mismatch on the second T of the sequence:
The starting point of our project was to insert the expression cassette for the intracellular enzyme DeHa2 (Part BBa_K5109001) into our chosen E. coli strain, DH5α, as it was already widely used in our laboratory and it’s very efficient in the expression of orthologous proteins.
After the sequence arrived at our lab, we started our cloning protocols: to insert our intracellular expression cassette containing DeHa2 (Part BBa_K5109001) into the pJUMP29-1A vector (Part BBa_J428341), our designed backbone, we used the digestion-ligation method with the BioBrick prefix and suffix.
During the first two months of work, we couldn’t get any results from the cloning trials. So we decided to give a chance to a different technique that uses homologous recombination. In this technique, both vector and insert are amplified by PCR with primers that have overlapping ends, and E. coli’s ability to perform in vivo homologous recombination allows for our insert and vector’s extremities to pair, be cut and then fused together, obtaining a closed vector. [1]
The purpose of the work was to clone the DeHa2 type 2 intracellular expression tool (Part BBa K5109001), inside our chosen backbone pJUMP29-1A. The first strategy of RFC 10 cloning wasn’t showing any results, so we designed and ordered specific primers to perform the recombination.
After our first unsuccessful attempt, we tried to clone three new expression cassettes, this time for the extracellular expression of DeHa2 (BBa_K5109023), Dehalogenase S (BBa_K5109020) and Laccase S (BBa_K5109022): all of these cassettes contain a Lpp-OmpT-linker part (BBa_K5109004) to create a display system for the enzymes, placed upstream of the GOIs. We cloned them simultaneously, using the same protocols and reagents, so that all three of them had the same chance of succeeding.
Since time was starting to become a limiting factor, we decided not to try the intracellular expression of the enzyme DehalogenaseS (BBa_K5109013) and Laccase S (BBa_K5109015) and to instead try directly the extracellular expression using the display system Lpp-OmpT, so that it would be a more interesting study during our expression and functionality assays.
We were planning to create a new composite part for the expression of Laccase E found in E. coli’s genome thanks to our bioinformatic analysis. Due to time restrictions we ordered the extracellular expression cassette containing Laccase E’s coding sequence, hoping we would be able to clone it. However, due to issues to this composite part’s synthesis, we were not able to get it shipped and perform the ligation and digestion process with it.
In order to test the correct functioning of dehalogenases, we decided to set some tests that would use chloroacetic acid. Dehalogenases are able to break the bond that connects halogens to the carbon chain so, if the protein expressed by E. coli is correctly functioning, there would be the degradation of the molecule of the chloroacetic acid.
We tested 2 colonies (#4 and #9) of E. coli Top10F’ transformed with the Lpp-OmpT-DeHa2 construct by creating a medium composed of LB, chloroacetic acid 2.5 mM and IPTG 5 uM. We sampled the bacterial cultures after 0, 24 and 48 hours and treated the samples to lysate and remove the cells, in order to make them compatible
with the mass spectrometry analysis[2][3]. Every time point was treated with two different procedures, in order to determine both the concentration of chloroacetic acid in the medium and inside the cells and to be able to evaluate the internalization of the compound by E. coli.
The samples that we prepared were analyzed in the chemistry facility of our university.
Samples were thawed, diluted 1:100 with water/acetonitrile 50:50 and analyzed by FIA-HRMS (flow injection analysis - high resolution mass spectrometry). Briefly, 20 µL of sample were injected in the mass spectrometer (Q-Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer,
Thermo Fisher Scientific, Germany) by using acetonitrile as eluent at 0.300 mL/min flow.
Data acquisition was performed in negative ionization. The capillary voltage was set to 2.8kV, capillary temperature was 320°C, auxiliary gas and sheath gas were nitrogen (300°C) at 20 and 10 psi, respectively. Resolution was set to 35000, AGC target was 3x10 6 and max injection time was 200 ms. Full-scan range was within
m/z 50-250. Calibration was performed by Pierce ESI Negative Ion Calibration Solution (Thermo Fisher Scientific, Germany). The pseudo-chromatographic peaks of chloroacetate were identified and integrated by considering the Extracted Ion Chromatogram (EIC) of the [M-H] - species selected with a window of 5 ppm.